Princeton Capital Management LLC decreased its stake in The Procter & Gamble Company (NYSE:PG) by 7.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,160 shares of the company’s stock after selling 249 shares during the quarter. Princeton Capital Management LLC’s holdings in The Procter & Gamble were worth $426,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also made changes to their positions in PG. Sanders Capital LLC bought a new stake in shares of The Procter & Gamble in the second quarter worth about $989,563,000. Franklin Resources Inc. increased its holdings in shares of The Procter & Gamble by 30.2% in the first quarter. Franklin Resources Inc. now owns 17,715,905 shares of the company’s stock worth $2,399,267,000 after acquiring an additional 4,108,666 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of The Procter & Gamble by 35.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 10,631,943 shares of the company’s stock worth $1,439,884,000 after acquiring an additional 2,793,345 shares in the last quarter. Beacon Capital Management Inc. increased its holdings in shares of The Procter & Gamble by 27,777.8% in the second quarter. Beacon Capital Management Inc. now owns 2,575,071 shares of the company’s stock worth $211,568,000 after acquiring an additional 2,565,834 shares in the last quarter. Finally, Mn Services Vermogensbeheer B.V. bought a new stake in shares of The Procter & Gamble in the second quarter worth about $193,631,000. Institutional investors own 62.51% of the company’s stock.
Shares of PG traded up $0.77 during midday trading on Tuesday, hitting $143.66. The company’s stock had a trading volume of 158,562 shares, compared to its average volume of 8,002,793. The Procter & Gamble Company has a one year low of $121.54 and a one year high of $147.23. The company’s fifty day simple moving average is $142.44 and its two-hundred day simple moving average is $137.21. The company has a quick ratio of 0.52, a current ratio of 0.70 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $348.85 billion, a price-to-earnings ratio of 26.03, a price-to-earnings-growth ratio of 3.47 and a beta of 0.43.
The business also recently announced a quarterly dividend, which was paid on Monday, August 16th. Shareholders of record on Friday, July 23rd were issued a dividend of $0.8698 per share. The ex-dividend date was Thursday, July 22nd. This is an increase from The Procter & Gamble’s previous quarterly dividend of $0.66. This represents a $3.48 annualized dividend and a yield of 2.42%. The Procter & Gamble’s payout ratio is presently 61.48%.
In other The Procter & Gamble news, CAO Michael G. Homan sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 3rd. The stock was sold at an average price of $144.04, for a total transaction of $1,440,400.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Shailesh Jejurikar sold 22,344 shares of the business’s stock in a transaction that occurred on Wednesday, August 11th. The stock was sold at an average price of $142.75, for a total value of $3,189,606.00. Following the sale, the chief executive officer now directly owns 38,466 shares of the company’s stock, valued at $5,491,021.50. The disclosure for this sale can be found here. Insiders sold a total of 748,024 shares of company stock worth $106,760,698 over the last three months. 0.51% of the stock is owned by company insiders.
A number of research firms recently issued reports on PG. Citigroup increased their price objective on The Procter & Gamble from $150.00 to $154.00 and gave the stock a “neutral” rating in a report on Monday, August 2nd. UBS Group assumed coverage on The Procter & Gamble in a research note on Wednesday, June 23rd. They issued a “neutral” rating and a $138.00 price target for the company. Zacks Investment Research raised The Procter & Gamble from a “hold” rating to a “buy” rating and set a $149.00 price objective for the company in a research report on Tuesday, July 20th. Erste Group raised The Procter & Gamble from a “hold” rating to a “buy” rating in a research report on Friday, August 20th. Finally, Morgan Stanley raised their price objective on The Procter & Gamble from $160.00 to $161.00 and gave the company an “overweight” rating in a research report on Tuesday, September 7th. Ten equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $151.63.
About The Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment comprises of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading: Hold Rating
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG).
Receive News & Ratings for The Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.